Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01078844
NCT01078844TerminatedNot Applicable

Memantine in Adult Autism Spectrum Disorder

Johns Hopkins University1 site in 1 country4 target enrollmentStarted: February 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
4
Locations
1
Primary Endpoint
Clinical Global Impression-Scale(CGI-S)
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Placebo

Placebo Comparator

Treatment as usual plus placebo

Intervention: Placebo (Drug)

memantine

Active Comparator

Treatment as usual plus memantine

Intervention: memantine (Drug)

Outcomes

Primary Outcomes

Clinical Global Impression-Scale(CGI-S)

Time Frame: 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Early Phase 1
Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance SpectroscopyAutism Spectrum Disorder
NCT02811627University of Missouri-Columbia10
Unknown
Phase 4
Memantine Treatment in Alzheimer's Disease PatientsAlzheimer Disease
NCT03168997Wei Cuibai222
Completed
Phase 3
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismAutism
NCT00498173Massachusetts General Hospital60
Completed
Not Applicable
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderAutistic DisorderAsperger SyndromeAutism Spectrum DisorderPervasive Developmental Disorder
NCT03170453University of Pittsburgh86
Completed
Not Applicable
Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderAutistic DisorderAutism Spectrum DisorderPervasive Developmental DisorderAsperger's Syndrome
NCT00902798University of Pittsburgh54